Lab Technology
Verder Scientific's Multi-Brand Approach to Pharmaceutical Innovation
Julia Buckley
Verder Scientific
PAO-04-24-PHEX-23Jun 16, 2025
R&D Funding
Cutting Public R&D Would Slash U.S. GDP, Innovation, and Industry Growth, New Report Warns
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-15Apr 30, 2025
NIH
The White House’s War on the NIH and the Disasters Ahead
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-05Mar 24, 2025
Magnetogenetics
Magnetogenetics and the Future of Remote Biological Control
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-04Mar 17, 2025
Collaboration
Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-14Mar 03, 2025
NIH Funding
NIH Funding Cuts Put Innovation, Health Equity, and Lives at Risk
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-03Feb 10, 2025
Bbiotherapeutics
Protein Science and the Future of Biotherapeutics
Mathias Uhlén, Ph.D.
NorthX Biologics
PAO-01-25-CL-07Jan 22, 2025
Protein Portfolio
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
Bio-Techne Corporation
PR-01-25-NI-05Jan 10, 2025
Synthetic Biology
Queensland University of Technology's Cutting-Edge Synthetic Biology Lab
Queensland University of Technology (QUT)
PAO-11-24-RTM-06Nov 15, 2024
AI
Plan Ahead: Mastering Your AI Budget for 2025 Success
Stephen Tharp
Dotmatics
PAO-10-24-CL-06Oct 07, 2024
Biosimilars
Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-07Jul 16, 2024
Biosimilars
Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-06Jul 16, 2024
Biosimilars
Navigating the Global Regulatory Landscape for Biosimilars
Veronica Grimoldi
Biosidus
PAO-07-24-CL-09Jul 16, 2024
Chronic Diseases
Transforming the Management of Chronic Diseases with Biosimilars
Hugo Sotelo; Jorge Catella
Biosidus
PAO-07-24-CL-10Jul 16, 2024
Women's Health
Revolutionizing Biologics (and Biology) through a Focus on Women
Chia Chia Sun; Gardiner Smith
Fab Biopharma
PAO-07-24-CL-03Jul 09, 2024
3D Cell Culture
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.
Corning Life Sciences
PAO-09-23-CL-02Sep 29, 2023
Data Management
Who is Using FAIR Data in Life Sciences R&D Today?
Christian Olsen
Dotmatics
PAO-09-23-CL-05Sep 11, 2023
R&D
Integrating Digital Solutions to Streamline Biopharma Operations
Christian Olsen
Dotmatics
PAO-07-23-CL-06Jul 17, 2023
Biomanufacturing
Biologics Outsourcing: Decision Drivers and Key Considerations
Scorpius BioManufacturing
PAO-04-23-CL-01Apr 18, 2023
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
Chris Berger; Kilian Witzel
Avid Bioservices
PAO-02-23-CL-03Mar 14, 2023